Honda S - Search Results

1

Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.

Haruta M, Arai Y, Watanabe N, Fujiwara Y, Honda S, Ohshima J, Kasai F, Nakadate H, Horie H, Okita H, Hata J, Fukuzawa M, Kaneko Y. Haruta M, et al. Among authors: honda s. Cancer Sci. 2012 Jun;103(6):1129-35. doi: 10.1111/j.1349-7006.2012.02269.x. Epub 2012 Apr 19. Cancer Sci. 2012. PMID: 22409817 Free PMC article.

2

Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.

Haruta M, Arai Y, Sugawara W, Watanabe N, Honda S, Ohshima J, Soejima H, Nakadate H, Okita H, Hata J, Fukuzawa M, Kaneko Y. Haruta M, et al. Among authors: honda s. Genes Chromosomes Cancer. 2008 Aug;47(8):712-27. doi: 10.1002/gcc.20572. Genes Chromosomes Cancer. 2008. PMID: 18464243

3

The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.

Honda S, Haruta M, Sugawara W, Sasaki F, Ohira M, Matsunaga T, Yamaoka H, Horie H, Ohnuma N, Nakagawara A, Hiyama E, Todo S, Kaneko Y. Honda S, et al. Int J Cancer. 2008 Sep 1;123(5):1117-25. doi: 10.1002/ijc.23613. Int J Cancer. 2008. PMID: 18537155

4

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.

Honda S, Arai Y, Haruta M, Sasaki F, Ohira M, Yamaoka H, Horie H, Nakagawara A, Hiyama E, Todo S, Kaneko Y. Honda S, et al. Br J Cancer. 2008 Dec 2;99(11):1891-9. doi: 10.1038/sj.bjc.6604754. Epub 2008 Oct 28. Br J Cancer. 2008. PMID: 19034281 Free PMC article.

5

Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes.

Furukawa S, Haruta M, Arai Y, Honda S, Ohshima J, Sugawara W, Kageyama Y, Higashi Y, Nishida K, Tsunematsu Y, Nakadate H, Ishii M, Kaneko Y. Furukawa S, et al. Among authors: honda s. Cancer Sci. 2009 Apr;100(4):698-708. doi: 10.1111/j.1349-7006.2009.01102.x. Epub 2009 Feb 24. Cancer Sci. 2009. PMID: 19245437 Free PMC article.

6

Genome-wide analysis of allelic imbalances reveals 4q deletions as a poor prognostic factor and MDM4 amplification at 1q32.1 in hepatoblastoma.

Arai Y, Honda S, Haruta M, Kasai F, Fujiwara Y, Ohshima J, Sasaki F, Nakagawara A, Horie H, Yamaoka H, Hiyama E, Kaneko Y. Arai Y, et al. Among authors: honda s. Genes Chromosomes Cancer. 2010 Jul;49(7):596-609. doi: 10.1002/gcc.20770. Genes Chromosomes Cancer. 2010. PMID: 20461752

7

RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.

Honda S, Miyagi H, Suzuki H, Minato M, Haruta M, Kaneko Y, Hatanaka KC, Hiyama E, Kamijo T, Okada T, Taketomi A. Honda S, et al. Pediatr Surg Int. 2013 Nov;29(11):1147-52. doi: 10.1007/s00383-013-3371-z. Pediatr Surg Int. 2013. PMID: 23989600

8

Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates.

Honda S, Minato M, Suzuki H, Fujiyoshi M, Miyagi H, Haruta M, Kaneko Y, Hatanaka KC, Hiyama E, Kamijo T, Okada T, Taketomi A. Honda S, et al. Cancer Sci. 2016 Jun;107(6):812-9. doi: 10.1111/cas.12928. Epub 2016 Apr 27. Cancer Sci. 2016. PMID: 26991471 Free PMC article.

9

Spontaneous rupture of an advanced pancreatoblastoma: aberrant RASSF1A methylation and CTNNB1 mutation as molecular genetic markers.

Honda S, Okada T, Miyagi H, Minato M, Suzuki H, Taketomi A. Honda S, et al. J Pediatr Surg. 2013 Apr;48(4):e29-32. doi: 10.1016/j.jpedsurg.2013.02.038. J Pediatr Surg. 2013. PMID: 23583162

10

Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system.

Saeki I, Ida K, Kurihara S, Watanabe K, Mori M, Hishiki T, Yokoi A, Fujimura J, Honda S, Nogami Y, Iehara T, Kazama T, Sekiguchi M, Kitagawa N, Matsumura R, Nomura M, Yamada Y, Hanaki R, Kaneda H, Takama Y, Inoue T, Tanaka Y, Miyazaki O, Nagase H, Takimoto T, Yoshimura K, Hiyama E. Saeki I, et al. Among authors: honda s. Pediatr Blood Cancer. 2024 Nov;71(11):e31255. doi: 10.1002/pbc.31255. Epub 2024 Aug 10. Pediatr Blood Cancer. 2024. PMID: 39126361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,943 results

Search Page

Filters